Showing 461 - 480 results of 65,233 for search '(( 50 ((a decrease) OR (mean decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 0.66s Refine Results
  1. 461
  2. 462

    Inclusion of SRRM4-regulated exons is decreased in tumors and cancer cell lines. by Sarah A. Head (6066398)

    Published 2021
    “…(B) SRRM4 target exons with respect to their average PSI in normal tissues. Red points are exons with PSI decreasing by at least 5% in at least 1 tumor type. …”
  3. 463

    Quantitation of seeding activity in brain tissue from a sporadic CJD patient using end-point RT-QUIC. by Hanae Takatsuki (754161)

    Published 2015
    “…The 5×10<sup>–9</sup> dilution yielded no reaction, as did a negative control consisting of A-CSF. (b) The percentage of positive reaction decreased in a sigmoidal curve within the dilution range when BH was used as the seed. …”
  4. 464

    The most stressor items in ENSS. by Phu Dinh Vu (19429477)

    Published 2024
    “…Overall, participants reported a medium stress level with an Extended Nursing Stress Scale (ENSS) mean score of 1.79 points, and 32.1% had occupational stress. …”
  5. 465

    S1 Data - by Phu Dinh Vu (19429477)

    Published 2024
    “…Overall, participants reported a medium stress level with an Extended Nursing Stress Scale (ENSS) mean score of 1.79 points, and 32.1% had occupational stress. …”
  6. 466
  7. 467
  8. 468
  9. 469
  10. 470
  11. 471
  12. 472

    Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer by Ana Alfaro (280118)

    Published 2016
    “…The risk conferred by each variant for developing CC earlier than 50 years was analyzed using a univariate logistic regression model considering old-aged patients (≥ 50 years) and non-HPV16 cases as the reference variables. …”
  13. 473
  14. 474
  15. 475

    Effect of specific inhibitors on CYP-mediated CK (50 μM) metabolism in HLMs. by Jian Xiao (253329)

    Published 2016
    “…<p>Note: Furafylline, tranylcypromine, sulfaphenazole, quinidine, chlormethiazole, ticlopidine, and ketoconazole were used as the specific inhibitors for CYP1A2, CYP2A6, CYP2C9, CYP2D6, CYP2E1, and CYP2C19, respectively. …”
  16. 476
  17. 477
  18. 478
  19. 479
  20. 480